Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial

The ERS International Congress 2020, Virtual

This annual event brings together the world's respiratory experts to showcase all the latest advances in respiratory medicine and science.

Due to the COVID-19 pandemic, in 2020 the ERS International Congress took place for the first time in a completely virtual format.

What is new in interstitial lung diseases of known origin?

Chair(s): B. Crestani (Paris, France), R. Borie (Paris, France)

Session type: Oral Presentation

Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial

K. Flaherty (Ann Arbor, MI, United States of America), A. Wells (London, United Kingdom), V. Cottin (Lyon, France), A. Devaraj (London, United Kingdom), Y. Inoue (Sakai City, Osaka, Japan), L. Richeldi (Rome, Italy), S. Walsh (London, United Kingdom), M. Kolb (Hamilton, Ontario, Canada), D. Koschel (Coswig, Germany), T. Moua (Rochester, MN, United States of America), S. Stowasser (Ingelheim am Rhein, Germany), R. Goeldner (Biberach, Germany), R. Schlenker-Herceg (Ridgefield, CT, United States of America), K. Brown (Denver, CO, United States of America)

CDN Connection Issue

The ERS International Congress 2020, Virtual

Limited Access

#{title}